# Controlled  Release of Multiple Drugs from Electrospun Fiber Membranes in the Local Treatment of Glioblastoma

> **NIH NIH R15** · UNIVERSITY OF CINCINNATI · 2020 · $481,543

## Abstract

Glioblastoma multiforme (GBM) is the most aggressive brain tumor with > 90 % recurrence rate and short
median survival time (< 15 months). Because GBM recurrence mostly occurs within ~2 cm of the original
lesion, a locally diffusing treatment should be very effective to significantly extend median survival.
Currently, carmustine (bis-chloroethyl-nitrosourea - BCNU) loaded discs (Gliadel®) provide local drug
delivery, implanted into the cavity created after tumor resection. However, there are limitations including
a short effective release period (~5-7 days) and non-conformity to the resection cavity due to stiff,
unmalleable polymeric disc form. The long-term goal of this proposal is to develop improved methods for
controlled, local drug delivery for treating GBM. The objective of this application is to investigate the use
of complex, multi-layered fiber membranes as an optimized vehicle for drug delivery. The central
hypothesis of this grant, based on successful preliminary animal trial data (with >150-day survival), is that
core-sheath fibers formed by coaxial electrospinning can provide a superior drug release profile with
controlled initial release and extended long term drug delivery. The core-sheath fiber construct also lends
itself to multiple drug release due to its composition of two or more individual components. Multi-layered
porous membrane discs and pouches can provide designed (“programmed”) release of drug molecules for
“cocktail” therapy.
The project consists of three specific aims: (1) Fabricate core-sheath fiber membranes with various
polymer hosts for optimum mechanical strength, flexibility, biocompatibility, and ability to incorporate
specific drug molecules. Transform planar (thin, large area) membranes into 3-D formulations (discs and
pouches) for surgical implantation. (2) Investigate drug release mechanisms from planar membranes, discs
and pouches in order to realize programmable long-term (months) drug delivery. Investigate in detail
controlled dual drug release from multi-layered core-sheath fiber membrane discs. Sequential drug release
was recently demonstrated using TMZ or BCNU and acriflavine (ACF) by embedding ACF-incorporated
discs within TMZ or BCNU-incorporated membranes. Combinations of current anti-cancer drugs (BCNU,
TMZ, paclitaxel) and potential new drug candidates (ACF, disulfiram) will be investigated to obtain the most
synergistic combination for localized cocktail chemotherapy. (3) Demonstrate (a) improved inhibition of
cancer cell growth in vitro and (b) extended survival rate using established in vivo animal models. This
study proposes the innovative use of complex multi-layered fibers for controlled release of incorporated
drug molecules for the treatment of GBM. The project has the potential to provide significant improvement
in the outcome of patients with GBM by developing a novel material system for drug delivery in a
bioavailable, biocompatible form.

## Key facts

- **NIH application ID:** 10046749
- **Project number:** 1R15CA252987-01
- **Recipient organization:** UNIVERSITY OF CINCINNATI
- **Principal Investigator:** Andrew Jules Steckl
- **Activity code:** R15 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $481,543
- **Award type:** 1
- **Project period:** 2020-09-01 → 2024-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10046749

## Citation

> US National Institutes of Health, RePORTER application 10046749, Controlled  Release of Multiple Drugs from Electrospun Fiber Membranes in the Local Treatment of Glioblastoma (1R15CA252987-01). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10046749. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*